Sara Anvari: Urticaria and/or Angioedema Events Secondary to mRNA Covid-19 Vaccinations -Updates from a National Case Registry
Dr Sara Anvari (Baylor College of Medicine, Texas Children’s Hospital, TX, USA) talks about her presentation on the COVID-19 Vaccine Allergy Case Registry, where potential cases of severe hypersensitivity reactions to COVID-19 vaccines were collected.
James Alexander: COVID-19 Vaccination in Patients with IBD on Immunosuppressants
Dr James Alexander (Imperial College London, London, UK) discusses the impact of immunosuppressant drugs on COVID-19 vaccine responses in patients with IBD.
ACR 2021: Therapeutic Options for COVID-19
TouchIMMUNOLOGY were delighted to talk with Professor Luis Ostrosky (Infectious diseases, UTHealth, Houston, TX, USA) around his presentation titled ‘COVID-19: Update on Therapeutics‘, which was presented at the ACR Convergence, 3-9 November 2021.
ACR 2020: Tocilizumab for COVID-19 Infection
It was a pleasure to be able to speak with John Stone (Massachusetts General Hospital, Boston, MA, USA) about the findings from his investigations into tocilizumab as a therapy for COVID-19 infection.
ESMO 2020 – The ORF1ab of SARS-CoV-2 Encodes an Immunodominant Epitope Restricted by HLA-A*01:01
touchIMMUNOLOGY meets meets Dr Pia Kvistborg at the Virtual 2020 ESMO Congress to discuss the presentation of her late-breaking abstract ‘The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01’ (LBA73) and initial findings from her recent study. at the Virtual 2020 ESMO Congress to discuss the presentation of her late-breaking abstract ‘The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01’ (LBA73) and initial findings from her recent study.
DDW 2021: Hepatic Manifestations of COVID-19
It was a pleasure to speak with Prof. Nancy Reau (Rush Medical College, Chicago, IL, USA) about the hepatic manifestations of COVID-19 infection.
Education activities are developed by touchIME for touchIMMUNOLOGY.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!